Robert Lermond v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2020)
Case summary [AI summaries can sometimes make mistakes]
Robert Lermond filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered Guillain-Barre Syndrome (GBS) as a result of his October 12, 2016 influenza vaccination. The respondent, the Secretary of Health and Human Services, reviewed the petition and medical records and conceded that Mr.
Lermond was entitled to compensation. The respondent indicated that medical personnel concluded that Mr.
Lermond suffered the Table injury of GBS following a flu vaccine within the Table time period, and there was no preponderance of evidence that his GBS was due to an unrelated factor. The claim also met the statutory severity requirements because Mr.
Lermond experienced sequelae of his GBS for more than six months. A ruling on entitlement was issued on August 30, 2018, finding Mr.
Lermond entitled to compensation. Subsequently, on January 29, 2020, the parties filed a joint stipulation for damages.
Chief Special Master Corcoran adopted the stipulation, awarding Mr. Lermond a lump sum of $475,000.00.
This amount represents compensation for all items of damages, including pain and suffering, past and future unreimbursed medical expenses, and actual and anticipated loss of earnings.
Source PDFs
USCOURTS-cofc-1_17-vv-01921